The discovery of I-NCMs’ ability to simultaneously patrol blood vessels and infiltrate tumor environments opens new possibilities for treating therapy-resistant cancers.

Mortality rates for hiatal hernia repairs vary significantly between elective (1.3%) and emergency (8%) procedures, emphasizing the importance of timely intervention when complications arise.

For sedentary individuals, matching the activity levels of the most physically active population segment (160 minutes of daily walking at 3 mph) could extend life expectancy by up to 11 years.

Workplace exposure to harmful chemicals remains a significant risk factor for bladder cancer, particularly affecting specific occupations and requiring targeted prevention strategies.

Durvalumab consolidation therapy demonstrated unprecedented survival benefit in limited-stage SCLC, extending median overall survival by nearly two years compared to placebo.

Poor metabolizers of UGT1A1 face a significantly increased risk of severe neutropenia from irinotecan therapy, making genetic testing crucial for appropriate dose modification.